Literature DB >> 6827704

Acute hemorrhagic conjunctivitis Investigation of a large-scale community outbreak in Dade County, Florida.

P A Patriarca, I M Onorato, V E Sklar, L B Schonberger, R M Kaminski, M H Hatch, D M Morens, R K Forster.   

Abstract

An outbreak of acute hemorrhagic conjunctivitis (AHC) due to enterovirus type 70 occurred in Dade County, Florida, from September to December 1981. Younger age groups, members of larger households, and the poor were at significantly greater risk of acquiring AHC than others in the community. Schoolchildren were most likely to introduce AHC into the household. After exclusion of all affected children from school, there was a dramatic reduction in reported cases, with attack ratesups, members of larger households, and the poor were at significantly greater risk of acquiring AHC than others in the community. Schoolchildren were most likely to introduce AHC into the household. After exclusion of all affected children from school, there was a dramatic reduction in reported cases, with attack ratesups, members of larger households, and the poor were at significantly greater risk of acquiring AHC than others in the community. Schoolchildren were most likely to introduce AHC into the household. After exclusion of all affected children from school, there was a dramatic reduction in reported cases, with attack rates declining more rapidly for school-aged children than for other age groups. Although AHC spread readily among family members, a retrospective study of 124 affected households showed an association between lower attack rates and simple hygienic measures. Should outbreaks of AHC recur, measures to reduce transmission should include exclusion of affected schoolchildren and educating the public about hygienic precautions.

Entities:  

Mesh:

Year:  1983        PMID: 6827704     DOI: 10.1001/jama.249.10.1283

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  7 in total

1.  Identification of a new strain of fastidious enterovirus 70 as the causative agent of an outbreak of hemorrhagic conjunctivitis.

Authors:  L M Shulman; Y Manor; R Azar; R Handsher; A Vonsover; E Mendelson; S Rothman; D Hassin; T Halmut; B Abramovitz; N Varsano
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

2.  Seasonal and Temporal Trends in Childhood Conjunctivitis in Burkina Faso.

Authors:  Ali Sié; Abdramane Diarra; Ourohiré Millogo; Augustin Zongo; Elodie Lebas; Till Bärnighausen; James Chodosh; Travis C Porco; Michael S Deiner; Thomas M Lietman; Jeremy D Keenan; Catherine E Oldenburg
Journal:  Am J Trop Med Hyg       Date:  2018-05-10       Impact factor: 2.345

3.  Detection of enterovirus 70 with monoclonal antibodies.

Authors:  L J Anderson; M H Hatch; M R Flemister; G E Marchetti
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

4.  Quantitation of enterovirus 70 antibody by microneutralization test and comparison with standard neutralization, hemagglutination inhibition, and complement fixation tests with different virus strains.

Authors:  J C Hierholzer; P G Bingham; R A Coombs; Y O Stone; M H Hatch
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

5.  Virological and epidemiological analysis of coxsackievirus A24 variant epidemic of acute hemorrhagic conjunctivitis in Okinawa, Japan, in 2011.

Authors:  Kazuhiro Harada; Tsuguto Fujimoto; Yoshimori Asato; Eiichi Uchio
Journal:  Clin Ophthalmol       Date:  2015-06-15

6.  Molecular epidemiology of acute hemorrhagic conjunctivitis caused by coxsackie A type 24 variant in China, 2004-2014.

Authors:  Li Zhang; Na Zhao; Xiaodan Huang; Xiuming Jin; Xingyi Geng; Ta-Chien Chan; Shelan Liu
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

7.  Taipei's use of a multi-channel mass risk communication program to rapidly reverse an epidemic of highly communicable disease.

Authors:  Muh-Yong Yen; Tsung-Shu Joseph Wu; Allen Wen-Hsiang Chiu; Wing-Wai Wong; Po-En Wang; Ta-Chien Chan; Chwan-Chuen King
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.